5 ms·
> There are huge information asymmetries involved when it comes to medical drugs... This is what the FDA should be doing. Correcting information asymmetries. W
by drcube 13y ago
> There are huge information asymmetries involved when it comes to medical drugs...
This is what the FDA should be doing. Correcting information asymmetries. With labeling requirements, unbiased PSAs, drug pamphlets and literature. Not telling people what they can and can't put in their bodies, or what businesses can and can't sell on the open market.
In fact, I'd say most government regulatory functions should be set up this way. Clearly inform and educate your citizens, don't opaquely dictate the behavior of your subjects.
- deleted 13y ago[deleted]
- PeterisP 13y agoWell, but this is exactly what they are doing here - the letter claims that they required corrections in the marketing claims (which would be correcting information asymmetries / labeling requirements), this wasn't done properly for a long time, so they are now enforcing it. For any reasonable requirement, if people/companies don't comply then it has to escalate to [threats of] harsher actions in order to force the reasonable thing to actually happen.